J. Belderbos

发表

M. Martel, J. Lebesque, J. Hayman, 2001 .

Recent advances in radiotherapy for lung cancer

D. Ruysscher, J. Belderbos, 2012 .

Cons: should a medically inoperable patient with a T2N0M0 non-small cell lung cancer central in the lung hilus be treated using stereotactic body radiotherapy?

U. Nestle, J. Belderbos, 2015, Translational lung cancer research.

Surgery after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer: why pneumonectomy should be avoided.

H. Klomp, J. V. van Sandick, N. van Zandwijk, 2010, Lung cancer.

Consensus report IASLC workshop Bruges, September 2002: pretreatment minimal staging for non-small cell lung cancer.

G. Scagliotti, P. Rocmans, H. Pass, 2003, Lung cancer.

Reply: Patterns of nodal recurrence after omission of elective nodal irradiation for limited-stage small-cell lung cancer

S. Senan, P. Baas, J. Belderbos, 2007, British Journal of Cancer.

Non-small cell lung carcinoma of the superior sulcus: favourable outcomes of combined modality treatment in carefully selected patients.

H. Klomp, N. van Zandwijk, J. Burgers, 2008, Lung cancer.

Are memantine, methylphenidate and donepezil effective in sparing cognitive functioning after brain irradiation?

J. Belderbos, D. Brandsma, Rosa Wartena, 2018, Journal of Cancer Metastasis and Treatment.

Excessive esophageal toxicity in patients with locally advanced non-small cell lung cancer treated with concurrent hypofractionated chemoradiotherapy and 3-weekly platinum doublet chemotherapy

E. Kouwenhoven, N. C. van der Voort van Zyp, C. G. Gadellaa-van Hooijdonk, 2022, Clinical and translational radiation oncology.

The Influence of a Multi-disciplinary Meeting for Quality Assurance on Target Delineation in Radiotherapy Treatment Preparation

R. Gilles, M. Verheij, C. Rasch, 2009 .

Rebuttal from Dr Nestle and Dr Belderbos.

U. Nestle, J. Belderbos, 2015, Translational lung cancer research.

Dose escalation in NSCLC using three dimensional conformal radiotherapy (3 DCRT)

J. Lebesque, P. Baas, J. Belderbos, 2000 .

Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: small-cell lung cancer (SCLC).

B. Jeremic, M. Martel, G. Videtic, 2008, International journal of radiation oncology, biology, physics.

DNA‐adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy

H. Bartelink, D. de Jong, A. Begg, 2000, International journal of cancer.

NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy

D. de Ruysscher, J. Laurent, M. Verheij, 2015, Journal of Translational Medicine.

Induction treatment before surgery for non-small cell lung cancer.

R. Mirimanoff, J. Pignon, A. Gregor, 2003, Lung cancer.

489 Normal tissue complication probabilities for irradiation of NSCLC patients with and without elective nodal irradiation

I. Barillot, J. Lebesque, J. Belderbos, 1997 .

O-145 Prognostic significance of the 18FDG-PET standardized uptake value for inoperable non-small cell lung cancer patients after high-dose radiotherapy

Ronald Boellaard, Adriaan A. Lammertsma, Joos V. Lebesque, 2005 .

The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Stage III Non-Small Cell Lung Cancer Patients Treated With Curative Chemoradiation.

E. Dieleman, N. C. van der Voort van Zyp, J. Pomp, 2022, Clinical lung cancer.

Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients.

M. Taphoorn, J. Heimans, W. Vandertop, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality assurance and safety of hippocampal avoidance prophylactic cranial irradiation in the multicenter randomized phase III trial (NCT01780675)

D. de Ruysscher, E. Damen, M. D. de Ruiter, 2023, Journal of the National Cancer Center.

Dose-escalation by boosting radiation dose within the primary tumor on the basis of a pre-treatment FDG-PET-CT scan in stage II and III NSCLC: A randomized phase II trial

D. Ruysscher, J. Belderbos, 2010 .

Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study

J. V. van Meerbeeck, S. Senan, P. Baas, 2006, British Journal of Cancer.

An Off-Line 4D Cone Beam CT Based Correction Protocol for Lung Tumor Motion

J. Sonke, J. Lebesque, M. Herk, 2005 .

The Discordance between Patient- and Clinician Reported Outcomes During (Chemo-)Radiation Therapy for Lung Cancer

G. Rossi, M. Kwint, I. Walraven, 2023, SSRN Electronic Journal.

Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival.

J. Lebesque, K. de Jaeger, J. Belderbos, 2005, International journal of radiation oncology, biology, physics.

UvA-DARE ( Digital Academic Repository ) Radiotherapy for lung cancer

J. Lebesque, J. Belderbos, R. Folz, 2017 .

Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?

J. Bussink, D. de Ruysscher, G. Bootsma, 2016, Lung cancer.